MustGrow achieves 100% control of root rot disease that infects major protein crops of plant origin

  • Root rot control Aphanomyces zoospores in laboratory tests.

  • Outstanding Efficiency: 100% control at economical application rates within 24 hours.

  • Aphanomyces is a soil-borne root rot disease that destroys pea, lentil and legume crops.

Saskatoon, Saskatchewan – (Newsfile Corp. – January 20, 2021) – MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Society“,”DoitGrow“) is pleased to announce the successful results of laboratory testing of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces“) via independent third-party facility: 100% control at economical application rates within 24 hours. MustGrow will now move to greenhouse and larger scale field testing. Study results and applicability are protected by patent under the existing suite of patents issued by MustGrow.

MustGrow’s remarkably safe and effective biological biopesticide is herbal – exploit the natural defense mechanism of mustard seed to fight against diseases, pests and weeds with an organic food grade biopesticide.

Aphanomyces is an aquatic mold pathogen that causes root rot, infecting a variety of peas, lentils, and other legumes collectively called legumes. The disease causes severe root damage and wilt, with yield losses ranging from 10% to 100% in infected fields (1). Canada is one of the world’s largest producers (~ 9.2 million tonnes; 2019) and exporter of pulses (2). Industry experts estimate annual legume crop losses in Canada at $ 20 million and worldwide $ 100 million caused by Aphanomyces (1). Current treatment measures cannot control Aphanomyces – they can only slow the spread and reduce the incidence and severity of the disease.

“It’s great to see MustGrow’s mustard-based biopesticide continue to be effective, especially with 100% disease control measured at exceptionally low application rates. The level of hard-to-kill disease control that we continue to achieve combined with our product’s beneficial soil health properties offers an excellent opportunity to improve yields for farmers and a more robust food supply, ”said Colin. Bletsky, COO of MustGrow. “I am optimistic that we can potentially provide a valuable crop protection tool for pulse producers.”

Plant-based crop protection for proteins of plant origin

MustGrow believes that it is both logical and ecological to protect plant-based protein crops with plant protection inputs. MustGrow’s product is a pre-plant soil treatment, which means that soil application takes place before crops are planted. The application of MustGrow’s biopesticide returns organic plant material to the soil through this pre-plant treatment process as a potential alternative to the use of synthetic chemicals.

According to Markets and Markets and analysis by EY-Parthenon, the global vegetable protein market size is expected to grow from US $ 12 billion in 2019 to US $ 28 billion by 2025 (15% CAGR). This is attributed to several factors, primarily the growing consumer health awareness, the increasing prevalence of high protein legume food products, and technological innovations in plant-based protein extraction. To meet the increased demand for vegetable proteins, Fior Markets estimates that the global pulse market will grow from US $ 16.2 billion in 2017 to US $ 24.3 billion by 2025 (CAGR of 5.2%).

Interest in MustGrow’s plant-based biopesticide is increasing as farmers, consumers and investors seek “natural organic” alternatives to synthetic chemical pesticides. Adverse climatic and weather events are expected to negatively impact the food supply of a growing human population. Warmer temperatures are expected to increase pest infestations and with more pests there will be more crop damage. The development of safe and effective biopesticides will be essential for future food security and environmentally sustainable agriculture.

(1) Globenewswire, 3rd party market research, MustGrow estimates

About MustGrow

MustGrow is a publicly traded company (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) agricultural biotechnology company focused on providing natural science-based biological solutions for high value crops including fruits and vegetables and other industries. MustGrow has designed and has a natural solution approved by the US EPA that uses the natural defense mechanism of mustard seed to protect plants against pests and diseases. Over 110 independent tests have been performed, validating MustGrow’s safe and effective signature products. The product, in pellet form, is approved by the EPA in all major US states and by Health Canada’s Pest Management Regulatory Agency (PMRA) as a biopesticide for high value crops such as fruits and vegetables. MustGrow has now concentrated a liquid format, TerraMG, and with regulatory approval, could be applied via standard drip or spray equipment, improving functionality and performance characteristics. Additionally, this new mustard-derived technology could have other applications in several different industries, from pre-planting soil treatment to post-harvest pest and disease control.

The Company has approximately 40.7 million basic common shares issued and outstanding and 50.6 million fully diluted shares. For more details, please visit


“Corey Giasson”

Director & CEO
Phone: + 1-306-668-2652
[email protected]

Forward-looking statements

Certain statements included in this press release constitute “forward-looking statements” that involve known and unknown risks, uncertainties and other factors that could affect the results, performance or achievements of MustGrow.

In general, forward-looking information can be identified by the use of forward-looking terms such as “plans”, “expects”, “is not anticipating”, or “believes”, or variations of such words and phrases or statements. that certain actions, events or results “could”, “could”, “would”, “could”, “occur” or “be achieved”.

Forward-looking statements are subject to a number of risks and uncertainties which may cause MustGrow’s actual results to differ materially from those discussed in such forward-looking statements, and even if such actual results are realized or substantially realized, it does not. can be assured that they will have the expected consequences or effects on MustGrow.

These risks are further described in MustGrow’s prospectus and other continuous disclosure documents filed by MustGrow with applicable securities regulatory authorities and available at Readers are invited to refer to these documents for more detailed information on MustGrow, which is subject to the reservations, assumptions and notes set forth therein.

This press release does not constitute an offer to sell or a solicitation of offers to buy any securities in the United States.

Neither CSE nor its regulatory services provider (as that term is defined in CSE policies) accepts responsibility for the adequacy or accuracy of this release.

© 2021 MustGrow Biologics Corp. All rights reserved.

To view the source version of this press release, please visit

Leave A Reply

Your email address will not be published.